| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Gastroenterology Division, Department of Medicine, University of Maryland School of Medicine and Gastroenterology Service, Department of Medicine, Baltimore Veterans Administration Hospital Baltimore, Maryland 21201 [F. S., Y. X., J. Y., Y. M., T-T. Z., S. W., K. D., F. M. S., J. M. A., S. J. M.]; Department of Pathology, The Mount Sinai School of Medicine, New York, New York 10029 [N. H., A. L.]; and Division of Surgical Oncology, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland 21201 [D. S.]
The p14ARF protein directly inhibits the MDM-2 oncoprotein, which mediates degradation of the p53 protein. It has been shown that p14ARF expression is frequently down-regulated by p14ARF gene hypermethylation in colorectal cancer. To determine whether p14ARF inactivation was involved in ulcerative colitis (UC)-associated carcinogenesis, the frequency and timing of p14ARF methylation was investigated in four different histological stages of UC-associated carcinogenesis. Methylation-specific PCR and bisulfite sequencing were used to determine the prevalence of p14ARF gene methylation. p14ARF methylation was observed in 19 of 38 (50%) adenocarcinomas, 4 of 12 (33%) dysplasias, and 3 of the 5 (60%) nonneoplastic UC mucosae. In contrast, 3 of 40 (3.7%) normal tissues showed p14ARF methylation (
2 test: P = 0.0003). Bisulfite sequencing was used to analyze 28 CpGs of p14ARF gene in 20 samples. The number of methylated CpGs ranged from 0 to 4, 0 to 20, and 0 to 28 in the normal, dysplastic, and carcinomatous samples, respectively (Kruskall-Wallis test: P = 0.0005). Densely methylated alleles were detected only in carcinomas by bisulfite sequencing. In conclusion, our data suggest that methylation of p14ARF is a relatively common early event in UC-associated carcinogenesis. p14ARF offers potential as a biomarker for the early detection of cancer or dysplasia in UC. Finally, analyses of p14ARF methylation in other organs should explore not only frank cancers but other premalignant lesions.
This article has been cited by other articles:
![]() |
T. TAHARA, T. SHIBATA, T. ARISAWA, M. NAKAMURA, H. YAMASHITA, D. YOSHIOKA, M. OKUBO, N. MARUYAMA, T. KAMANO, Y. KAMIYA, et al. Impact of Catechol-O-methyltransferase (COMT) Gene Polymorphism on Promoter Methylation Status in Gastric Mucosa Anticancer Res, July 1, 2009; 29(7): 2857 - 2861. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M.E.I. Hellebrekers, M. H.F.M. Lentjes, S. M. van den Bosch, V. Melotte, K. A.D. Wouters, K. L.J. Daenen, K. M. Smits, Y. Akiyama, Y. Yuasa, S. Sanduleanu, et al. GATA4 and GATA5 are Potential Tumor Suppressors and Biomarkers in Colorectal Cancer Clin. Cancer Res., June 15, 2009; 15(12): 3990 - 3997. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yan, G. Dalmasso, H. T. T. Nguyen, T. S. Obertone, L. Charrier-Hisamuddin, S. V. Sitaraman, and D. Merlin Nuclear Factor-{kappa}B Is a Critical Mediator of Ste20-Like Proline-/Alanine-Rich Kinase Regulation in Intestinal Inflammation Am. J. Pathol., October 1, 2008; 173(4): 1013 - 1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Mahon, P. Baril, V. Bhakta, C. Chelala, K. Caulee, T. Harada, and N. R. Lemoine S100A4 Contributes to the Suppression of BNIP3 Expression, Chemoresistance, and Inhibition of Apoptosis in Pancreatic Cancer Cancer Res., July 15, 2007; 67(14): 6786 - 6795. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Watanabe, T. Kobunai, E. Toda, T. Kanazawa, Y. Kazama, J. Tanaka, T. Tanaka, Y. Yamamoto, K. Hata, T. Kojima, et al. Gene Expression Signature and the Prediction of Ulcerative Colitis-Associated Colorectal Cancer by DNA Microarray Clin. Cancer Res., January 15, 2007; 13(2): 415 - 420. [Abstract] [Full Text] [PDF] |
||||
![]() |
A O O Chan, J Z Peng, S K Lam, K C Lai, M F Yuen, H K L Cheung, Y L Kwong, A Rashid, C K Chan, and B C-Y Wong Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation Gut, April 1, 2006; 55(4): 463 - 468. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Paliwal, S. Pande, R. C. Kovi, N. E. Sharpless, N. Bardeesy, and S. R. Grossman Targeting of C-Terminal Binding Protein (CtBP) by ARF Results in p53-Independent Apoptosis. Mol. Cell. Biol., March 1, 2006; 26(6): 2360 - 2372. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Fujii, K Tominaga, K Kitajima, J Takeda, T Kusaka, M Fujita, K Ichikawa, S Tomita, Y Ohkura, Y Ono, et al. Methylation of the oestrogen receptor gene in non-neoplastic epithelium as a marker of colorectal neoplasia risk in longstanding and extensive ulcerative colitis Gut, September 1, 2005; 54(9): 1287 - 1292. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Itzkowitz and X. Yio Inflammation and Cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation Am J Physiol Gastrointest Liver Physiol, July 1, 2004; 287(1): G7 - G17. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Kopelovich, J. A. Crowell, and J. R. Fay The Epigenome as a Target for Cancer Chemoprevention J Natl Cancer Inst, December 3, 2003; 95(23): 1747 - 1757. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. O. O. Chan, S. K. Lam, B. C.-Y. Wong, Y.-L. Kwong, A. Rashid, and G. Tamura Gene Methylation in Non-Neoplastic Mucosa of Gastric Cancer: Age or Helicobacter pylori Related? Am. J. Pathol., July 1, 2003; 163(1): 370 - 373. [Full Text] [PDF] |
||||
![]() |
Y Kaneko, S Sakurai, M Hironaka, S Sato, S Oguni, Y Sakuma, K Sato, K Sugano, and K Saito Distinct methylated profiles in Helicobacter pylori dependent and independent gastric MALT lymphomas Gut, May 1, 2003; 52(5): 641 - 646. [Abstract] [Full Text] |
||||
![]() |
D. N. Seril, J. Liao, G.-Y. Yang, and C. S. Yang Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models Carcinogenesis, March 1, 2003; 24(3): 353 - 362. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Sato, D. Shibata, N. Harpaz, Y. Xu, J. Yin, Y. Mori, S. Wang, A. Olaru, E. Deacu, F. M. Selaru, et al. Aberrant Methylation of the HPP1 Gene in Ulcerative Colitis-associated Colorectal Carcinoma Cancer Res., December 1, 2002; 62(23): 6820 - 6822. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |